Welcome : Guest

Avexa Ltd. (Australia) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Avexa Ltd., which is principally involved in Biotechnology Business. Illustrated with 20 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-30939
Price: $1000
Company Type: Public
Pages: 21
Date: June 2016
Market Data Tables: 20

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Hepatitis B......2
Table 1: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......2
Table 2: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......3
Table 3: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......4
Antibiotics......5
Table 4: Antibiotics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......5
Table 5: Antibiotics Market by Category in China (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......6
Table 6: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines......7
Anti-Diabetic Drugs......8
Table 7: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......8
Table 8: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......9
Table 9: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......10
Clinical Trials......11
Table 10: Clinical Trials by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Africa, Asia, Australia, Canada, Europe, Mexico, South America, and United States......11
HIV ......12
Table 11: Leading HIV Testing Competitors Worldwide......12
Table 12: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others (Includes NNRTIs)......13
HIV Regimens for New Start Patients......14
Table 13: HIV Regimens for New Start Patients by Segment in European Union (2014) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......14
Table 14: HIV Regimens for Experienced Patients by Segment in the US (2014) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......15
Table 15: HIV Regimens for New Start Patients by Segment in the US (2014) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......16
Infectious Disease Drugs......17
Table 16: Infectious Disease Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......17
Table 17: Infectious Disease Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......18
Malarial Infection......19
Table 18: Population Suspected with Malarial Infection Worldwide (2015) - Percentage Share Breakdown by Volume for Population Exposed to Infection, Population Suspected of Infection, Uninfected Population and Others......19
Acne Drugs......20
Table 19: Acne Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......20
Infectious Disease Drugs......21
Table 20: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......21